Reklāma
Bluebird Bio Q3 Loss Narrows, Tops Estimates; Revenues Miss Estimates
(RTTNews) - Bluebird Bio, Inc. (BLUE) reported Tuesday a net loss for the third quarter of $71.73 million or $0.66 per share, narrower than $76.52 million or $0.94 per share in the prior-year quarter.
Total revenues for the quarter soared to $12.39 million from $0.01 million in the same quarter last year, primarily due to SKYSONA and ZYNTEGLO product revenue. On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.67 per share on revenues of $13.41 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Bluebird Bio Says FDA Accepts BLA For Lovotibeglogene Autotemcel For Priority Review
bluebird bio, Inc. (BLUE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for lovotibeglogene autotemcel (lovo-cel) for priority review. The agency has set a Prescription Drug User Fee Act (PDUFA) goal date of December 20, 2023.
RTTNews
|
798 days ago
Euro Falls Amid Political Uncertainty
The euro weakened against other major currencies in the European session on Wednesday, as trader's concern about the collapse of France's government.
RTTNews
|
3h 7min ago
Bay Street Likely To Open On Positive Note
Canadian shares are likely to open on a positive note on Wednesday, riding on strong earnings from Royal Bank of Canada and National Bank of Canada. Weak commodity prices and concerns on the geopolitical and tariffs front may weigh limit market's upside.
RTTNews
|
3h 32min ago
European Stocks Turning In Mixed Performance
European stocks are turning in a mixed performance on Wednesday as political uncertainty in France, and a lack of any significant positive triggers render the mood cautious. Investors are also awaiting earnings updates from AI major NVIDIA.
RTTNews
|
3h 59min ago
FTSE 100 Flat In Lackluster Trade; Bank Stocks Drifting Lower
U.K. stocks are somewhat subdued in lackluster trade on Wednesday as investors remain a bit reluctant to make significant moves due to a lack of triggers.
The benchmark FTSE 100 was at 9,266.25 a little before noon, up 0.45 points over previous close.
RTTNews
|
4h 49min ago
CAC 40 Advances After Recent Losses
Despite the uncertainty on the political front, the French market is up in positive territory on Wednesday due largely to some bargain hunting at several counters after two successive days of declines. Investors are also looking ahead to AI giant Nvidia's earnings updates.
RTTNews
|
5h 3min ago
DAX Remains Weak Despite Paring Some Early Losses
German stocks are down in negative territory in cautious trade on Wednesday amid political uncertainty in France ahead of a confidence vote early next month, and anxiety ahead of Nvidia's earnings for clues on the AI trade.
RTTNews
|
5h 20min ago
Mixed Sentiment In Asian Markets
Asian markets moved in a mixed fashion on Wednesday amidst anxiety ahead of release of earnings update by chip-giant NVIDIA.
RTTNews
|
5h 31min ago
